Mather Group, Llc. Neogenomics Inc Transaction History
Mather Group, Llc.
- $9.81 Billion
- Q3 2025
A detailed history of Mather Group, Llc. transactions in Neogenomics Inc stock. As of the latest transaction made, Mather Group, Llc. holds 305 shares of NEO stock, worth $3,153. This represents 0.0% of its overall portfolio holdings.
Number of Shares
305Holding current value
$3,153% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding NEO
# of Institutions
291Shares Held
131MCall Options Held
1.3MPut Options Held
395K-
Black Rock Inc. New York, NY19.7MShares$203 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$144 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN9.93MShares$103 Million9.2% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD8.22MShares$85 Million2.48% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.97MShares$61.8 Million0.02% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.3B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...